Evidence map›Paper›PMID 35011465›Full record

ReviewMolecules (Basel, Switzerland)2021

Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects.

Md Mominur Rahman, Md Saidur Rahaman, Md Rezaul Islam, Firoza Rahman, Faria Mannan Mithi, Taha Alqahtani, Mohannad A Almikhlafi, Samia Qasem Alghamdi, Abdullah S Alruwaili, Md Sohel Hossain and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 336 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
336citing papers in PubMed, 3 pooled it
38.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

336 citing papers in PubMed, 3 syntheses or guidelines pooled it, 765 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. PlantInternational journal of molecular sciences · 2026
    Review
  15. Article
  16. Phenolic compounds fromResearch in pharmaceutical sciences · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Review

276 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 2 countries.

Md Mominur RahmanDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.ORCID 0000-0003-2357-283X
Md Saidur RahamanDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.ORCID 0000-0002-6634-3255
Md Rezaul IslamDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.
Firoza RahmanDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.
Faria Mannan MithiDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.ORCID 0000-0001-7824-0117
Taha AlqahtaniDepartment of Pharmacology, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.ORCID 0000-0003-4017-8754
Mohannad A AlmikhlafiDepartment of Pharmacology and Toxicology, Taibah University, Madinah 41477, Saudi Arabia.
Samia Qasem AlghamdiDepartment of Biology, Faculty of Science, Al-Baha University, Albaha 65527, Saudi Arabia.ORCID 0000-0001-9292-7900
Abdullah S AlruwailiDepartment of Clinical Laboratory, College of Applied Medical Science, Northern Border University, P.O. Box 1321, Arar 9280, Saudi Arabia.
Md Sohel HossainDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.
Muniruddin AhmedDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh.
Rajib DasDepartment of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh.ORCID 0000-0001-7852-4080
Talha Bin EmranDepartment of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh.ORCID 0000-0003-3188-2272
Md Sahab UddinDepartment of Pharmacy, Southeast University, Dhaka 1213, Bangladesh.ORCID 0000-0002-0805-7840
Daffodil International University · BDAl Baha University · SABGC Trust University Bangladesh · BDKing Khalid University · SANorthern Border University · SASoutheast University · BDTaibah University · SAUniversity of Dhaka · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is a natural protective mechanism that occurs when the body's tissue homeostatic mechanisms are disrupted by biotic, physical, or chemical agents. The immune response generates pro-inflammatory mediators, but excessive output, such as chronic inflammation, contributes to many persistent diseases. Some phenolic compounds work in tandem with nonsteroidal anti-inflammatory drugs (NSAIDs) to inhibit pro-inflammatory mediators' activity or gene expression, including cyclooxygenase (COX). Various phenolic compounds can also act on transcription factors, such as nuclear factor-κB (NF-κB) or nuclear factor-erythroid factor 2-related factor 2 (Nrf-2), to up-or downregulate elements within the antioxidant response pathways. Phenolic compounds can inhibit enzymes associated with the development of human diseases and have been used to treat various common human ailments, including hypertension, metabolic problems, incendiary infections, and neurodegenerative diseases. The inhibition of the angiotensin-converting enzyme (ACE) by phenolic compounds has been used to treat hypertension. The inhibition of carbohydrate hydrolyzing enzyme represents a type 2 diabetes mellitus therapy, and cholinesterase inhibition has been applied to treat Alzheimer's disease (AD). Phenolic compounds have also demonstrated anti-inflammatory properties to treat skin diseases, rheumatoid arthritis, and inflammatory bowel disease. Plant extracts and phenolic compounds exert protective effects against oxidative stress and inflammation caused by airborne particulate matter, in addition to a range of anti-inflammatory, anticancer, anti-aging, antibacterial, and antiviral activities. Dietary polyphenols have been used to prevent and treat allergy-related diseases. The chemical and biological contributions of phenolic compounds to cardiovascular disease have also been described. This review summarizes the recent progress delineating the multifunctional roles of phenolic compounds, including their anti-inflammatory properties and the molecular pathways through which they exert anti-inflammatory effects on metabolic disorders. This study also discusses current issues and potential prospects for the therapeutic application of phenolic compounds to various human diseases.

Indexed as

AnimalsAntihypertensive AgentsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsBiological AvailabilityBiological ProductsDisease ManagementDrug Evaluation, PreclinicalHealth Impact AssessmentHumansHypoglycemic AgentsPhenolsPlant ExtractsStructure-Activity RelationshipAntihypertensive AgentsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsBiological ProductsHypoglycemic AgentsPhenolsPlant Extractsantioxidantcardiovascular diseasediabetic mellitushypertensioninflammationphenolic compounds

Identifiers

PMID35011465
PMCPMC8746501
OpenAlexW4205748791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.